Published in J Invest Dermatol on January 01, 2001
Characterization of the global profile of genes expressed in cervical epithelium by Serial Analysis of Gene Expression (SAGE). BMC Genomics (2005) 0.85
Serial Analysis of Gene Expression: Applications in Human Studies. J Biomed Biotechnol (2004) 0.81
The rate of wound healing is increased in psoriasis. J Dermatol Sci (2013) 0.80
A molecular signature of epithelial host defense: comparative gene expression analysis of cultured bronchial epithelial cells and keratinocytes. BMC Genomics (2006) 0.76
Expression profiling of calcium induced genes in cultured human keratinocytes. J Korean Med Sci (2010) 0.75
The effect of hyaluronan combined with KI3 complex (Hyiodine wound dressing) on keratinocytes and immune cells. J Mater Sci Mater Med (2006) 0.75
On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg (1999) 2.55
Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin. J Pathol (1997) 1.50
SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci (1994) 1.30
Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J Clin Invest (1985) 1.27
Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Investig Med (2000) 1.26
Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol (1998) 1.24
SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem (1993) 1.20
Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Exp Med (1989) 1.18
Hydrogen peroxide suppresses the proteoglycan synthesis of intact articular cartilage. J Rheumatol (1985) 1.17
Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest (1996) 1.15
Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-proteinase inhibitor. Br J Exp Pathol (1987) 1.13
Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry (2008) 1.11
Decreased PMN accumulation and glomerular damage by clodronate liposome treatment in PMN-dependent anti-GBM nephritis in mice. Exp Nephrol (1997) 1.10
Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol (2000) 1.08
Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. Br J Dermatol (2012) 1.07
TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch Dermatol Res (2000) 1.05
How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol (2010) 1.05
Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol (1996) 1.03
Differential expression of SKALP/Elafin in human epidermal tumors. Am J Pathol (1993) 1.01
Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene. Biol Chem (1997) 1.01
Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome? Ann Rheum Dis (2005) 1.00
Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis. Br J Dermatol (1997) 0.99
Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations. Clin Genet (2005) 0.99
Clinical and molecular overlap between myopathies and inherited connective tissue diseases. Neuromuscul Disord (2008) 0.99
Ratiometric measurement of intracellular pH in cultured human keratinocytes using carboxy-SNARF-1 and flow cytometry. Cytometry (1991) 0.98
Effects of experimental joint inflammation on bone marrow and periarticular bone. A study of two types of arthritis, using variable degrees of inflammation. Br J Exp Pathol (1985) 0.98
Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol (2009) 0.97
Differential effects of detergents on keratinocyte gene expression. J Invest Dermatol (1998) 0.97
Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. Am J Pathol (1989) 0.95
Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol (2001) 0.95
Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol (2001) 0.94
An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthritis Rheum (1986) 0.93
Immune deficiency in familial duodenal atresia. J Pediatr Surg (1996) 0.92
Ehlers-Danlos syndrome due to tenascin-X deficiency: muscle weakness and contractures support overlap with collagen VI myopathies. Am J Med Genet A (2007) 0.92
Allergic arthritis induced by cationic antigens: relationship of chronicity with antigen retention and T-cell reactivity. Immunology (1987) 0.91
Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. J Control Release (2006) 0.91
Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model. Arch Dermatol Res (2013) 0.91
Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis. Br J Dermatol (2009) 0.91
Long-range physical maps of two loci (Aps-1 and GP79) flanking the root-knot nematode resistance gene (Mi) near the centromere of tomato chromosome 6. Plant Mol Biol (1993) 0.90
Tenascin expression during wound healing in human skin. J Pathol (1996) 0.90
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. Br J Dermatol (2009) 0.90
Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma. J Pathol (1994) 0.89
Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06. Br J Dermatol (2012) 0.88
Tenascin expression in basal cell carcinoma. Br J Dermatol (1992) 0.88
The impact of protein size and charge on its retention in articular cartilage. J Rheumatol (1987) 0.87
Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study. J Pathol (1998) 0.87
Epidermal proliferation is not impaired in chronic venous ulcers. Acta Derm Venereol (1995) 0.87
In situ demonstration of phosphorylated c-jun and p38 MAP kinase in epidermal keratinocytes following ultraviolet B irradiation of human skin. J Pathol (2001) 0.87
Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature. J Biol Chem (1997) 0.86
Dermal connective tissue development in mice: an essential role for tenascin-X. Cell Tissue Res (2005) 0.86
A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X. Neth J Med (2004) 0.86
Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. J Invest Dermatol (1995) 0.86
Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus. Br J Cancer (1997) 0.86
Lack of albuminuria in the early heterologous phase of anti-GBM nephritis in beige mice. Kidney Int (1993) 0.85
Development and application of monoclonal antibodies against SKALP/elafin and other trappin family members. Arch Dermatol Res (2001) 0.85
Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature. Br J Dermatol (2010) 0.85
Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol Chem Hoppe Seyler (1995) 0.85
Cystatin M / E expression in inflammatory and neoplastic skin disorders. Br J Dermatol (2002) 0.85
Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13. Cytogenet Cell Genet (1994) 0.85
Identification and characterization of multiple species of tenascin-X in human serum. FEBS J (2007) 0.84
Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice. Nephrol Dial Transplant (1996) 0.84
Cell kinetic characterization of growth arrest in cultured human keratinocytes. J Cell Sci (1994) 0.84
Recurrent neuropathy associated with Ehlers-Danlos syndrome. J Neurol (2005) 0.83
Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology (2006) 0.83
Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate. Arch Dermatol Res (1996) 0.83
Expression of SKALP/elafin during wound healing in human skin. Arch Dermatol Res (1996) 0.82
The psychophysiological stress response in psoriasis and rheumatoid arthritis. Br J Dermatol (2014) 0.82
A molecularly defined array based on native fibrillar collagen for the assessment of skin tissue engineering biomaterials. Biomaterials (2009) 0.82
Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome. Connect Tissue Res (2011) 0.82
The inflammatory and proliferative response of normal skin in a model for acute chemical injury: ornithine decarboxylase induction as a common feature in various models for acute skin injury. Br J Dermatol (1994) 0.81
Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol (1998) 0.81
Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients. J Invest Dermatol (1992) 0.81
Immunofluorescent surface labelling, flow sorting and culturing of putative epidermal stem cells derived from small skin punch biopsies. J Immunol Methods (2002) 0.81
Expression of tenascin-C splice variants by human skin cells. Arch Dermatol Res (2000) 0.81
Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity. Arch Dermatol Res (1998) 0.81
Elastase-inhibiting activity in scaling skin disorders. Acta Derm Venereol (1990) 0.81
Increased elafin expression in cystic, dysplastic and neoplastic oral tissues. J Oral Pathol Med (1996) 0.81
Cell kinetic characterization of the epidermal growth factor dependent BALB/MK line using flow cytometric analysis of DNA content and iododeoxyuridine incorporation. Cell Prolif (1993) 0.80
Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes. Arch Dermatol Res (1998) 0.80
MON-150, a versatile monoclonal antibody against involucrin: characterization and applications. Arch Dermatol Res (1992) 0.80
An experimental model for hydrogen peroxide induced tissue damage: effect on cartilage and other articular tissues. Int J Tissue React (1987) 0.80
The 'metabolic burst' in polymorphonuclear leukocytes from patients with quiescent psoriasis. Br J Dermatol (1985) 0.80
Cryosectioning of hair follicles. An improved method using liquid nitrogen conduction freezing. Acta Derm Venereol (1990) 0.79
A histological and immunohistochemical study on chronic irritant contact dermatitis. Am J Contact Dermat (1998) 0.79
The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study. Arch Dermatol Res (1994) 0.79
Design and in vivo evaluation of a molecularly defined acellular skin construct: reduction of early contraction and increase in early blood vessel formation. Acta Biomater (2010) 0.78
Human epidermal keratinocytes are a source of tenascin-C during wound healing. J Invest Dermatol (1997) 0.78
Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation? Arch Dermatol Res (1996) 0.78
Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis (2002) 0.78
Cytokeratin expression in alopecia areata hair follicles. Acta Derm Venereol (1994) 0.78
Chondrocyte unresponsiveness to insulin-like growth factor-1. A novel pathogenetic mechanisms for cartilage destruction in experimental arthritis. Agents Actions (1989) 0.78